Yonghe Medical Group Co., Ltd. (HKG:2279)
Hong Kong · Delayed Price · Currency is HKD 1.970
-0.020 (-1.01%)
At close: Feb 13, 2026
Yonghe Medical Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -59.86 | -226.34 | -546.39 | -85.86 | 120.19 | 163.33 |
Depreciation & Amortization | 269.33 | 312.75 | 333.57 | 220.22 | 199.8 | 158.72 |
Other Amortization | 2.46 | 2.46 | 1.27 | 4.46 | 1.17 | 0.4 |
Loss (Gain) From Sale of Assets | 42.23 | 42.23 | 45.9 | -0.09 | 1.13 | 3.98 |
Asset Writedown & Restructuring Costs | 60.83 | 60.83 | 28.13 | - | - | - |
Loss (Gain) From Sale of Investments | -0.32 | -0.32 | 0.26 | 0.14 | -0.15 | 0.36 |
Stock-Based Compensation | 0.11 | 0.11 | 0.18 | 0.18 | 0.18 | 3.61 |
Other Operating Activities | 19.2 | 7.76 | 19.87 | -122.71 | 38.12 | 67.02 |
Change in Accounts Receivable | 35.32 | 35.32 | 0.15 | -1.94 | -8.21 | -45.84 |
Change in Inventory | 35.47 | 35.47 | 12.08 | -34.95 | -26.12 | -12.51 |
Change in Accounts Payable | -44.2 | -44.2 | 60.46 | -53.47 | 42.3 | 65.42 |
Change in Unearned Revenue | 7.7 | 7.7 | 27.38 | -34.55 | 68.88 | 97.07 |
Change in Other Net Operating Assets | -5.15 | -5.15 | - | - | - | - |
Operating Cash Flow | 363.13 | 228.62 | -17.15 | -108.56 | 437.28 | 501.57 |
Operating Cash Flow Growth | 343.92% | - | - | - | -12.82% | 174.86% |
Capital Expenditures | -39.41 | -45.66 | -159.19 | -240.57 | -181.63 | -142.2 |
Sale of Property, Plant & Equipment | 1.01 | 0.87 | 3.03 | 1.79 | 0.5 | 0.18 |
Cash Acquisitions | -0.37 | -0.37 | -1.6 | - | -3.8 | - |
Divestitures | - | - | 7.5 | - | - | 0.15 |
Sale (Purchase) of Intangibles | -4.5 | -8.1 | -12.12 | -2.94 | -9.01 | -0.64 |
Investment in Securities | - | - | 398.25 | -408.84 | - | 0.13 |
Other Investing Activities | - | - | 9.71 | - | - | - |
Investing Cash Flow | -43.27 | -53.26 | 245.58 | -650.57 | -193.94 | -142.39 |
Short-Term Debt Issued | - | 79.81 | 154.54 | 75.47 | 232.69 | 28.87 |
Total Debt Issued | 5 | 79.81 | 154.54 | 75.47 | 232.69 | 28.87 |
Short-Term Debt Repaid | - | -182.55 | -1.8 | -149.64 | -184.85 | -47.83 |
Long-Term Debt Repaid | - | -182.2 | -239.1 | -194.66 | -204.74 | -132.29 |
Total Debt Repaid | -300.61 | -364.75 | -240.9 | -344.3 | -389.6 | -180.12 |
Net Debt Issued (Repaid) | -295.61 | -284.94 | -86.37 | -268.84 | -156.91 | -151.25 |
Issuance of Common Stock | - | - | - | 91.88 | 1,381 | - |
Repurchase of Common Stock | -0.19 | -1.94 | -96.5 | -79.04 | - | - |
Common Dividends Paid | - | - | - | -43.16 | -69.8 | - |
Other Financing Activities | -1.85 | -3.84 | -2.34 | -33.89 | -125.8 | -4.87 |
Financing Cash Flow | -297.65 | -290.72 | -185.2 | -333.05 | 1,028 | -156.12 |
Foreign Exchange Rate Adjustments | -0.09 | -0.01 | -5.1 | 91.08 | 1.78 | - |
Net Cash Flow | 22.11 | -115.37 | 38.12 | -1,001 | 1,273 | 203.07 |
Free Cash Flow | 323.72 | 182.95 | -176.35 | -349.14 | 255.65 | 359.37 |
Free Cash Flow Growth | 1958.75% | - | - | - | -28.86% | 368.71% |
Free Cash Flow Margin | 18.33% | 10.14% | -9.92% | -24.71% | 11.79% | 21.93% |
Free Cash Flow Per Share | 0.64 | 0.36 | -0.35 | -0.68 | 0.59 | 0.86 |
Cash Interest Paid | 1.85 | 3.84 | 2.34 | 1.61 | 3.95 | 1.49 |
Cash Income Tax Paid | 3.7 | 4.47 | 5.5 | 58.11 | 103.92 | 40.67 |
Levered Free Cash Flow | 243.17 | 151.87 | -53.08 | -314.18 | 226.97 | 318.98 |
Unlevered Free Cash Flow | 263.38 | 177.63 | -19.23 | -282.16 | 259.43 | 341.66 |
Change in Working Capital | 29.14 | 29.14 | 100.07 | -124.91 | 76.85 | 104.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.